Cas:138579-66-5 Galanin (1-13)-Substance P (5-11) amide manufacturer & supplier

Chemical Name:Galanin (1-13)-Substance P (5-11) amide

CAS.NO:138579-66-5

Synonyms:M15;L-Methioninamide,glycyl-L-tryptophyl-L-threonyl-L-leucyl-L-asparaginyl-L-seryl-L-alanylglycyl-L-tyrosyl-L-leucyl-L-leucylglycyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl

Molecular Formula:C₁₀₄H₁₅₁N₂₅O₂₆S

Molecular Weight:2199.53000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:844.27000

Exact Mass:2198.10000

LogP:4.41220

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like M15 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Methioninamide,glycyl-L-tryptophyl-L-threonyl-L-leucyl-L-asparaginyl-L-seryl-L-alanylglycyl-L-tyrosyl-L-leucyl-L-leucylglycyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Methioninamide,glycyl-L-tryptophyl-L-threonyl-L-leucyl-L-asparaginyl-L-seryl-L-alanylglycyl-L-tyrosyl-L-leucyl-L-leucylglycyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl Use and application,M15 technical grade,usp/ep/jp grade.

Related News: “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. N-((2S,3S)-1-(isopropylcarbamoyl)-2,3-diphenylcyclopropyl)-1-pivaloylpyrrolidine-2-carboxamide manufacturers As of June’s end, there have been 100 reported GBS cases among J&J recipients, most of whom were hospitalized and one person has died, CDC officials reported. Most cases were seen in older men within 13 days following the single-dose vaccine. 6-(C-β-D-Xylopyranosyl)-chrysin suppliers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. 4-acetamido-1,5-naphthyridine vendor & factory “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. ,“In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources.